Seven Drug Makers Vie In Japan For Three New Diabetes Drugs
This article was originally published in PharmAsia News
Executive Summary
Seven drug makers, most Japan-based, are vying to get new diabetes-related products on the market next year as the nation faces an increase of patients with the disease, with Chugai, Kowa and Sanofi competing for the same treatment.